Tibet Rhodiola Pharmaceutical Holding Co.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000ZW7
CNY
41.94
0.14 (0.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
723.55
892.27
438.57
938.60
712.11
631.27
560.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
723.55
892.27
438.57
938.60
712.11
631.27
560.75
Raw Material Cost
51.38
53.47
53.73
60.27
45.84
60.85
49.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.15
10.38
2.06
1.99
0.00
0.08
3.96
Selling and Distribution Expenses
425.75
561.29
240.78
535.63
406.47
385.48
324.24
Other Expenses
1.63
3.11
0.28
1.01
0.38
1.01
0.08
Total Expenditure (Excl Depreciation)
503.60
656.20
299.33
607.97
456.16
456.47
378.70
Operating Profit (PBDIT) excl Other Income
219.89999999999998
236.1
139.2
330.6
256
174.8
182
Other Income
119.48
23.29
42.31
27.40
54.92
119.11
15.80
Operating Profit (PBDIT)
332.71
264.14
198.46
361.10
322.25
306.10
209.90
Interest
10.15
10.38
2.06
1.99
0.00
0.08
3.96
Exceptional Items
-2.14
2.08
0.40
0.60
-1.42
-14.95
0.34
Gross Profit (PBDT)
672.17
838.79
384.83
878.33
666.27
570.42
511.01
Depreciation
0.00
20.92
20.92
18.44
18.44
18.61
18.61
Profit Before Tax
320.42
234.92
175.89
341.27
302.39
272.46
187.66
Tax
33.80
39.09
18.02
35.13
31.40
7.33
17.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
298.71
216.15
154.45
298.04
269.28
259.42
168.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
298.71
216.15
154.45
298.04
269.28
259.42
168.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-15.88
-25.08
0.66
2.50
0.97
2.51
0.33
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
282.83
191.07
155.12
300.54
270.25
261.93
169.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,900.00
3,798.43
3,551.44
4,161.11
4,101.03
3,917.82
3,629.96
Earnings per share (EPS)
0.93
0.67
0.48
0.92
0.84
0.8
0.52
Diluted Earnings per share
0.93
0.67
0.48
0.92
0.84
0.8
0.52
Operating Profit Margin (Excl OI)
29.47%
24.65%
30.84%
33.59%
34.95%
26.67%
31.3%
Gross Profit Margin
44.28%
28.67%
44.88%
38.32%
45.05%
46.11%
36.79%
PAT Margin
41.28%
24.23%
35.22%
31.75%
37.81%
41.1%
30.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -18.92% vs 103.44% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 47.99% vs 23.21% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -11.46% vs 54.16% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -2.88% vs 395.24% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Tibet Rhodiola Pharmaceutical Holding Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
723.55
0
723.55
Other Operating Income
0.00
0.00
0.00
Total Operating income
723.55
0
723.55
Raw Material Cost
51.38
0
51.38
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.15
0
10.15
Selling and Distribution Expenses
425.75
0
425.75
Other Expenses
1.63
0.00
1.63
Total Expenditure (Excl Depreciation)
503.60
0
503.60
Operating Profit (PBDIT) excl Other Income
219.95
0.00
219.95
Other Income
119.48
0
119.48
Operating Profit (PBDIT)
332.71
0
332.71
Interest
10.15
0
10.15
Exceptional Items
-2.14
0
-2.14
Gross Profit (PBDT)
672.17
0
672.17
Depreciation
0.00
0
0.00
Profit Before Tax
320.42
0
320.42
Tax
33.80
0
33.80
Provisions and contingencies
0
0
0.00
Profit After Tax
298.71
0
298.71
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
298.71
0
298.71
Share in Profit of Associates
0
0
0.00
Minority Interest
-15.88
0
-15.88
Other related items
0.00
0.00
0.00
Consolidated Net Profit
282.83
0
282.83
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,900.00
0
3,900.00
Earnings per share (EPS)
0.93
0
0.93
Diluted Earnings per share
0.93
0
0.93
Operating Profit Margin (Excl OI)
29.47%
0%
0.00
29.47%
Gross Profit Margin
44.28%
0%
0.00
44.28%
PAT Margin
41.28%
0%
0.00
41.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 72.35 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -18.92% vs 103.44% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.60% vs 2.12% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 28.28 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 47.99% vs 23.21% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.66% vs -14.28% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.32 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -11.46% vs 54.16% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -20.24% vs 4.82% in Mar 2025

Quarterly - Interest
Interest 1.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.88% vs 395.24% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.47%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025